Protective Effects of Paeoniflorin Against Corticosterone-induced Neurotoxicity in PC12 Cells

被引:38
作者
Mao, Qing-Qiu [1 ,2 ]
Zhong, Xiao-Ming [1 ]
Qiu, Feng-Mei [1 ]
Li, Zhao-Yi [1 ]
Huang, Zhen [1 ]
机构
[1] Zhejiang Chinese Med Univ, Coll Pharm, Hangzhou 310053, Zhejiang, Peoples R China
[2] Chinese Univ Hong Kong, Sch Chinese Med, Shatin, Hong Kong, Peoples R China
关键词
Paeoniflorin; antidepressant; corticosterone; PC12; cells; neuroprotection; NERVE GROWTH-FACTOR; ANTIOXIDANT ENZYME CAPACITY; MORINDA-OFFICINALIS; OXIDATIVE INJURY; PEONY GLYCOSIDES; STRESS; DEPRESSION; BRAIN; MICE; GLUCOCORTICOIDS;
D O I
10.1002/ptr.3673
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Neuroprotection has been proposed as one of the acting mechanisms of antidepressants. Paeoniflorin, a monoterpene glycoside, has been reported to display antidepressant-like effects in animal models of behavioural despair. The present study aimed to examine the protective effect of paeoniflorin treatment on corticosterone-induced neurotoxicity in cultured rat pheochromocytoma (PC12) cells. Paeoniflorin was shown to elevate cell viability, decrease levels of intracellular reactive oxygen species (ROS) and malondialdehyde (MDA) in corticosterone-treated PC12 cells. Paeoniflorin also reversed the reduced nerve growth factor (NGF) mRNA level caused by corticosterone in PC12 cells. The results suggest that paeoniflorin exerts a neuroprotective effect on corticosterone-induced neurotoxicity in PC12 cells, at least in part, via the inhibition of oxidative stress and the up-regulation of NGF expression. This neuroprotective effect may be one of the action pathways that accounts for the in vivo antidepressant activity of paeoniflorin. Copyright (c) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:969 / 973
页数:5
相关论文
共 42 条
[1]   HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions [J].
Aihara, Masako ;
Ida, Itsuro ;
Yuuki, Naoya ;
Oshima, Akihiko ;
Kurnano, Hiroshi ;
Takahashi, Keisuke ;
Fukuda, Masato ;
Oriuchi, Noboru ;
Endo, Keigo ;
Matsuda, Hiroshi ;
Mikuni, Masahiko .
PSYCHIATRY RESEARCH-NEUROIMAGING, 2007, 155 (03) :245-256
[2]   Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression [J].
Angelucci, F ;
Aloe, L ;
Jiménez-Vasquez, P ;
Mathé, AA .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2003, 6 (03) :225-231
[3]   Antioxidative enzyme activities and lipid peroxidation in major depression:: alterations by antidepressant treatments [J].
Bilici, M ;
Efe, H ;
Köroglu, MA ;
Uydu, HA ;
Bekaroglu, M ;
Deger, O .
JOURNAL OF AFFECTIVE DISORDERS, 2001, 64 (01) :43-51
[4]   Neurotrophin-mediated rapid signaling in the central nervous system: Mechanisms and functions [J].
Blum, R ;
Konnerth, A .
PHYSIOLOGY, 2005, 20 :70-78
[5]  
Bouvier N, 2003, PRESSE MED, V32, P519
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]  
Cui G.Z., 2009, WORLD PHYTOMED, V24, P231
[8]   Alterations of neuroplasticity in depression:: the hippocampus and beyond [J].
Fuchs, E ;
Czéh, B ;
Kole, MHP ;
Michaelis, T ;
Lucassen, PJ .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 :S481-S490
[9]  
Goodman YD, 1996, J NEUROCHEM, V66, P1836
[10]   Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats [J].
Hellweg, R ;
Lang, UE ;
Nagel, M ;
Baumgartner, A .
MOLECULAR PSYCHIATRY, 2002, 7 (06) :604-608